Arthneeti
All Q2 FY27 results →
NB

Neochem Bio Solutions Ltd

Q2 FY27Chemicals & Petrochemicals

Neochem Bio Solutions Q2 Results 2026 (FY27): Revenue ₹68.9 Cr, PAT ₹7.8 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹105
Market cap₹179 Cr
P/E14.3
Updated29 Oct 2026
Read4 min read

Based on Neochem Bio Solutions Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] - EBITDA for H1 FY27: ₹12.4 crores, up 25% YoY; EBITDA margin at 18.0% vs 21.7% in H1 FY26 [Pages 4, 22] - Profit After Tax (PAT) for H1 FY27: ₹7.8 crores, up 43% YoY; PAT margin 11.3% vs 11.6% in H1 FY26 [Pages 4, 22] - EBITDA for H1 FY27: ₹12.4 crore, up 25% YoY - EBITDA margin for H1 FY27: 18.0%, down from 21.7% in H1 FY26 - Profit after tax (PAT) for H1 FY27: ₹7.8 crore, up 43% YoY - PAT margin for H1 FY27:

From Neochem Bio Solutions Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.

Revenue & Sales Performance

  • Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22]
  • EBITDA for H1 FY27: ₹12.4 crores, up 25% YoY; EBITDA margin at 18.0% vs 21.7% in H1 FY26 [Pages 4, 22]
  • Profit After Tax (PAT) for H1 FY27: ₹7.8 crores, up 43% YoY; PAT margin 11.3% vs 11.6% in H1 FY26 [Pages 4, 22]

2 more points from Neochem Bio Solutions Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Neochem Bio Solutions Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Manufacturing facility at Moraiya, Ahmedabad:
  • Installed capacity: 22,000 MTPA (Metric Tons Per Annum)
  • Capacity utilization in H1 FY27: 61.8%, increasing from 35% in FY24
  • Capital work-in-progress as of H1 FY27: ₹2.8 crores
  • Capex details:

2 more points from Neochem Bio Solutions Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries Ltd
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Neochem Bio Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The focus is on financial performance, operational capabilities, management overview, market opportunity, and other business highlights without reference to current or pending order volumes.

Continue your research

What Neochem Bio Solutions Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Sadhana Nitro (Q2 FY27)

    EBITDA for the quarter ended September 30, 2026: ₹1,051 lakh, a 21% year-on-year (YoY) increase. Key results statement takeaways from Sadhana Nitro Chem Ltd's Q

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Neochem Bio Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Neochem Bio Solutions Ltd Q2 FY27 results?

Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] - EBITDA for H1 FY27: ₹12.4 crores, up 25% YoY; EBITDA margin at 18.0% vs 21.7% in H1 FY26 [Pages 4, 22] - Profit After Tax (PAT) for H1 FY27: ₹7.8 crores, up 43% YoY; PAT margin 11.3% vs 11.6% in H1 FY26 [Pages 4, 22] - EBITDA for H1 FY27: ₹12.4 crore, up 25% YoY - EBITDA margin for H1 FY27: 18.0%, down from 21.7% in H1 FY26 - Profit after tax (PAT) for H1 FY27: ₹7.8 crore, up 43% YoY - PAT margin for H1 FY27:

What is Neochem Bio Solutions Ltd share price analysis?

Neochem Bio Solutions Ltd currently shows a neutral. The stock trades at a P/E of 14.3 with a market cap of ₹179 Cr. Investors should review the full earnings analysis for detailed insights.

Is Neochem Bio Solutions Ltd planning capital expenditure?

Manufacturing facility at Moraiya, Ahmedabad: - Installed capacity: 22,000 MTPA (Metric Tons Per Annum) - Capacity utilization in H1 FY27: 61.8%, increasing from 35% in FY24 - Capital work-in-pr

Keep Neochem Bio Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.